Piramal Pharma LimitedNSE: PPLPHARMA

Press Release Aug 21 2025

· Issued by Piramal Pharma Limited

Filed with NSE · · 5 pages · English

Summary by 6ix AI

Piramal Pharma Limited has issued a press release regarding a joint investment with NewAmsterdam Pharma to enhance oral solid dosage production capabilities at its Sellersville, Pennsylvania site. The investment will create a dedicated suite for fixed dose combination products, aimed at meeting high commercial demand for a specific investigational drug therapy.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Piramal Pharma Limited on 6ix

Earlier from Piramal Pharma

Later from Piramal Pharma

All Piramal Pharma news releases